Sunday, November 12, 2017

5:30 PM - 7:45 PM

Element Room

---

Overview

please note this symposium is presented by our Platinum Sponsor Indivior

---

Details

5:30pm - Drinks & Canapés, 6:00pm - Session starts, 7:15pm - Drinks and canapés, 7:45 - Close. --------------------------------------------------------------------- Buprenorphine has been studied and used for treatment of opioid dependence for over 2 decades yet buprenorphine pharmacology still confuses and polices and practice remain divergent. This symposium will look at buprenorphine dosing starting in the lab and finishing in the consultation room. The first speaker will revisit the pharmacology and pharmacodynamics of buprenorphine and what this predicts for safety and efficacy. The second speaker will discuss buprenorphine dose response observed in clinical studies. Finally a number of case studies will be reviewed, with participation from the audience, to see how all this may translate to patient care.